Editor’s Note: Recently Drs. Janet Weston and (current ADHS president) Virginia Berridge hosted a witness seminar, a method of oral history collection through group recollections, on the development of prison policy regarding HIV/AIDS since the early 1980s at LSHTM’S Centre for History in Public Health. Below is a more thorough description of the event that may be of interest Points readers. Contact Dr. Weston for more information at firstname.lastname@example.org.
Editor’s Note: This post is brought to you by Miriam Kingsberg, an assistant professor in the department of history at the University of Colorado, Boulder. This summer she visited the Deutsches Apotheken-Museum in Munich and has provided us with a review of its collections. All photos are courtesy of her as well. Enjoy!
During a two-month sojourn in Germany this summer, I eagerly anticipated a visit to Munich’s famed Beer and Octoberfest Museum—in the name of “research,” naturally. Less renowned than this hotspot and its many sister institutions, but equally relevant to historians of intoxicants, is the country’s sole attempt to reconstruct its pharmaceutical history: the Deutsches Apotheken-Museum (hereafter referred to as DAM), located since 1958 in the breathtaking Heidelberg Castle.
Editor’s Note: This conference summary is brought to you by David Korostyshevsky, a doctoral student in the History of Science, Technology, and Medicine at the University of Minnesota. He traveled to Dwight, Illinois, in mid-July to attend the ADHS off-year “I’ve Been to Dwight” conference, and has provided this account of his time there. Thanks David!
On July 14-18, 2016, a group of international alcohol and drug historians descended upon the village of Dwight, Illinois, for an ADHS off-year conference. Conference organizers selected Dwight because 2016 marks the 50th anniversary of the closing of the Keeley Institute.
Founded by Leslie E. Keeley in 1879 (and operating until 1966), the Keeley Institute offered treatment options to patients with addiction, usually alcoholism, including Keeley’s Gold Cure. “I’ve Been to Dwight,” the conference title, references “a catchphrase” former Keeley Institute patients “used to explain their sobriety.”
To make it easier to read, this summary is organized thematically. You can see the full conference program here.
I live-tweeted the conference as @rndmhistorian under the hashtag #IBTD16. Also, Janet Olson, volunteer archivist at the Frances Willard Historical Association wrote a blog post about the conference.
EDITOR’S NOTE: Points is thrilled to welcomeHannah Palin (Film Archives Specialist) and Nicolette Bromberg (Visual Materials Curator) from the University of Washington Libraries, Special Collections. The University of Washington has a wonderful collection of materials by the British filmmaker and journalist Adrian Cowell. Beware, alcohol and drugs historians– once you read their descriptions of the Cowell collection, you might be tempted to book your tickets to Seattle!
In January 2015, the University of Washington Libraries, Special Collections, received 6 pallets of materials shipped from London. They were stacked high with boxes of 16mm film, audio and videotape, photographs, newspaper clippings, transcripts and log books—covering three decades of work by British filmmaker and journalist, Adrian Cowell. From the 1960s to the 1990s, Adrian Cowell created television documentaries detailing the complex relationships between minority insurgents in a remote region of Burma and the international opium trade originating in Southeast Asia. The Adrian Cowell Film and Research Collection contains Cowell’s work tracking the opium trade from its production in Burma to the addicts and dealers in Hong Kong to the drug policy makers in Washington, D.C. It includes the most extensive collection of images of the remote Burmese Shan State in the world, gathered during Cowell’s trips documenting opium merchants, opium caravans, militias, insurgents and other activities related to the opium trade. A year and half after its arrival, Special Collections’ staff, students, and volunteers are still slowly working their way through the collection of over 2000 items, most of which have never before been made public.
EDITOR’S NOTE: Today, Points brings you the third in a series of posts on silencing and substance use by Heather Sophia Lee, PhD, LCSW, an Assistant Professor of Family Medicine and Community Health at Rutgers’ Robert Wood Johnson Medical School. You can read the first installment here and the second installment here.
For my dissertation, I conducted a qualitative study of two harm reduction programs. The purpose was to describe the experiences of participants in harm reduction programs given that “outcomes” of such programs were difficult to measure.
At that time evidence existed for the efficacy of harm reduction practices, like needle exchange programs, in reducing the spread of sexually transmitted diseases like HIV and hepatitis C. Less was known about the impact of harm reduction as a model for addiction treatment. Its broad focus made it unclear which “outcomes” were most important to measure. Coupled with political resistance, many agencies often avoided calling their work “harm reduction” to avoid scrutiny which might interfere with meeting the needs of their clients.
As a novice qualitative researcher, I was intuitively curious about how harm reduction was being integrated into twelve step recovery experiences. I was also interested in the extent to which one might be just as likely to come to abstinence through harm reduction as abstinence-only based treatment. Harm reduction and twelve step models were often cast as mutually exclusive, and I knew there was a deeper story to be known though I wasn’t yet sure what it was.
Alcohol and drugs historians have long lamented the archival limitations of studying past substance users. Substance users typically enter the historical record through retrospective oral histories, the archives of hospitals or prisons, or popular books and media. All these sources have shortcomings: oral histories are riddled with the errors of human memory, institutional archives are usually limited to clinical and criminal records, and popular culture is distorted by sensationalism or artistry. As Bob Beach, Miriam Kingsberg, and Joe Gabriel have argued on Points’ pages, finding the “user’s perspective” is historically difficult.
Editor’s Note: This week, Bob Beach continues his discussion of evidence in the archives. This essay is based on his recent trip to the Harry J. Anslinger Papers at Penn State University.
I know he was simply doing his job, but it was a strange experience. This was not my first archive trip. But when the gentleman in charge of the Harry Anslinger papers collection at Penn State approached, by way of introduction, I couldn’t help but notice that he was sizing me up, almost like a bouncer would size up a potential nightclub patron who looked much too young. Perhaps I should have worn a tie.
In an almost accusatorial tone, he wanted to know why I was there, what I was looking for in the collection, what my motives were. He gave me a brief lecture on the importance of accurate note-taking and documentation. After a few minutes talking to him, he realized that I was a serious researcher and would not pose any threat to the collection. But he shared vague war stories about people that have been through the collection, some of whom misrepresented the collection as a whole, and some who stole documents to add to personal collections to add ammunition to what seems like a never-ending war on our first drug czar.Read More »
For cultural historians looking into the history of drugs, one of the more frustrating obstacles to our work comes from trying to find “the people,” those who used the drugs we are studying. In studies of more recent times, scholars are able to locate individuals, interviewing them about their experiences. But for someone who studies the history of cannabis in the late nineteenth and early twentieth century, the archives are understandably lacking in user voices. In working through this problem, I’ve begun to problematize our conception of drug user. I’d like to share my thoughts and to perhaps get a discussion going in the comments section below.
Who uses drugs? A simple Google search of “drug users” yields a sponsored link for Unity Recovery Center, a rehab chain based in Florida. The next four results link to an assortment of informational websites on drug abuse and addiction. Finally, after the image results that, not surprisingly, feature “the faces of meth,” our search takes us to the Wikipedia article “Drug User” which defines the user as “a person who uses drugs either legally or illegally. A drug user may or may not also be a drug abuser, and may or may not have one or more drug addictions.”
Implicit in this definition is the assumption that drug users are only those folks that smoke, sniff, ingest, shoot, or otherwise consume a substance into their bodies. This is confirmed by the image that accompanies the article.Read More »
Editor’s Note: This post was written by Lucas Richert and Erika Dyck, and was originally published on The 2×2 Project, an online journal from Columbia University’s Department of Epidemiology.
In February 2014, Scientific American surprised readers with an editorial that called for an end to the ban on psychedelic drug research and criticized drug regulators for limiting access to such psychedelic drugs as LSD (Lysergic acid-diethylamide), ecstasy (MDMA), and psilocybin.
A few months later, Science further described how scientists are rediscovering these drugs as legitimate treatments as well as tools of investigation. “More and more researchers are turning back to psychedelics” to treat depression, obsessive-compulsive disorder, various addictions, and other categories of mental illness.
Historians of medicine and drugs have long held a view that psychoactive substances conform to cyclical patterns involving intense periods of enthusiasm, therapeutic optimism, critical appraisals, and finally limited use. The duration of this cycle has varied, but this historical model suggests psychedelics are due for a comeback tour. It was just a matter of time.